Company / Operating Income per Share
Niagen Bioscience, Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$0.21
FY2025
5-year range
-$0.40 / $0.21
FY2021-FY2025
Trend
+381.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share changed +382% YoY in FY2025, a notable deviation from the 9-year average annual change of -21052%.
Based on SEC 10-K filings.
0.21 in FY2025.
Improved from $-0.25 to $0.21 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Niagen Bioscience, Inc.'s operating income per share has grown for 3 consecutive years.
- In FY2025, operating income per share increased 381.9% year-over-year.
- Lowest operating income per share in the period was in FY2019.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.21 | +381.9% |
| FY2024 | -$0.07 | +70.1% |
| FY2023 | -$0.25 | +37.1% |
| FY2022 | -$0.40 | -23.9% |
| FY2021 | -$0.32 | +38.9% |
| FY2020 | -$0.53 | +99.9% |
| FY2019 | -$568.17 | -189661.7% |
| FY2018 | -$0.30 | +31.4% |
| FY2017 | -$0.44 | -440.6% |
| FY2016 | -$0.08 | -311.1% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026